Exploring the impact of xylazine on wound care needs

The animal tranquilizer xylazine is increasingly found in the illicit opioid supply nationwide, leading to severe wounds among people who use drugs. New research led by a University of Pittsburgh physician-scientist and published in Drug and Alcohol Dependence seeks to understand the wound care experiences of this population.

Cosmo confirms full redemption in cash of €175m Convertible Bonds – Biotech Investments

Cosmo Pharmaceuticals N.V. / Key word(s): Bond Cosmo confirms full redemption in cash of €175m Convertible Bonds 06.12.2023 / 06:00 GMT/BST Dublin, Ireland – 06

December 7, 2023

Pharma ad spending jumps 12% in first half of 2023, ad tracker says

Pharmaceutical advertisers are spending strong in 2023 so far, notching a 12% increase over last year’s first half. While they’re pouring billions of dollars into

July 27, 2023

Novartis expands Cosentyx reach for rheumatic diseases with IV version approval – Pharmaceutical Technology

The approval of Cosentyx as an IV formulation along with subcutaneous formulations broadens treatment options for patients. Credit: Pramote Polyamate via Getty Images. The US

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.